Mycenax Inc. is a biopharmaceutical product development and
manufacturing organization specializing in products
derived from mammalian cell culture and microbial
fermentation. Our highly experienced team of experts is
committed to use the best-in-class technology and
international standard of controls to move recombinant
protein and antibody products timely and
cost-effectively through clinical development. We employ
product-driven approach and business practices that meet
both regulatory and market requirements.
